Updates in Diagnosis and Management of Bladder Cancer Patients: From Prevention to Surgery and Beyond (Volume 2)

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Genitourinary Oncology".

Deadline for manuscript submissions: closed (15 June 2023) | Viewed by 409

Special Issue Editors


E-Mail Website
Guest Editor
Institute of Urology, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA
Interests: surgery; complications reporting; bladder cancer; artificial intelligence; patients safety; urology; minimally invasive surgery; adverse events; evidence-based medicine; quality reporting improvement
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Division of Urology and Urologic Oncology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Interests: bladder cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Bladder cancer is the ninth most common malignant ailment and the fourteenth most common cause of cancer death worldwide. 

We are seeking high impact review or research papers for our upcoming Special Issue focusing on Updates in Diagnosis and Management of Bladder Cancer Patients: from Prevention to Surgery and Beyond.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

  • Prevention of Bladder Cancer and patient counseling.
  • Diagnostic options related to molecular signature/platform, AI, and novel urine/blood biomarkers related to therapy or molecular subtypes.
  • Diagnostic tools (Blue Light, NBI, ecc).
  • Surgical approaches (Open, Robotic or Laparoscopic techniques).
  • Surgical training for radical cystectomy with urinary diversion.
  • Urinary Diversions (techniques and outcomes).
  • Enhanced after-recovery pathways.
  • Perioperative complications and management.
  • Strategies to improve the Quality of life.
  • Chemotherapy and immunotherapy.
  • Therapeutic options relating to new technology or biomarker implementations.
  • Patient rehabilitation after Radical cystectomy.
  • Follow up strategies.
  • Treatment of metastatic bladder cancer.

We look forward to receiving your contributions.

You may choose our Joint Special Issue in Cancers.

Dr. Giovanni E. Cacciamani
Dr. Saum Ghodoussipour
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • NBI cystoscopy
  • blue light cystoscopy
  • bladder cancer
  • ERAS
  • urothelial cancer
  • radical cystectomy
  • robotic radical cystectomy
  • smoking screening
  • immunotherapy

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop